BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34168443)

  • 1. A Novel Model-Based Questionnaire Based on Low-Dose CT Screening Data for Chronic Obstructive Pulmonary Disease Diagnosis in Shimane, Japan.
    Tanino A; Kawamura T; Hamaguchi M; Tanino R; Nakao M; Hotta T; Tsubata Y; Hamaguchi S; Isobe T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1823-1833. PubMed ID: 34168443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study.
    Tsukuya G; Samukawa T; Matsumoto K; Fukuyama S; Kumamoto T; Uchida A; Koriyama C; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1903-9. PubMed ID: 27574414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study.
    Weiss G; Steinacher I; Lamprecht B; Kaiser B; Mikes R; Sator L; Hartl S; Wagner H; Studnicka M
    NPJ Prim Care Respir Med; 2017 Jan; 27(1):4. PubMed ID: 28127061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of mass screening for chronic obstructive pulmonary disease using screening questionnaires in a medical health check-up population.
    Hanibuchi M; Saijo A; Mitsuhashi A; Kajimoto T; Kitagawa T; Nishioka Y
    Respir Investig; 2022 Nov; 60(6):815-821. PubMed ID: 36057534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study.
    Samukawa T; Matsumoto K; Tsukuya G; Koriyama C; Fukuyama S; Uchida A; Mizuno K; Miyahara H; Kiyohara Y; Ninomiya T; Inoue H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1469-1481. PubMed ID: 28553099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting.
    Sichletidis L; Spyratos D; Papaioannou M; Chloros D; Tsiotsios A; Tsagaraki V; Haidich AB
    Prim Care Respir J; 2011 Jun; 20(2):184-9, 1 p following 189. PubMed ID: 21597666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in the International Primary Care Airways Group Questionnaire for Screening of Chronic Obstructive Pulmonary Disease: A Retrospective, Cross-Sectional Study.
    Machiguchi H; Arizono S; Tawara Y; Oomagari M; Yanagita Y; Tanaka T; Senjyu H; Kozu R
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1467-1476. PubMed ID: 35769226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of Self-Administered Questionnaires for Identifying Individuals at Risk of COPD in Japan: The OCEAN (Okinawa COPD casE finding AssessmeNt) Study.
    Tamaki K; Sakihara E; Miyata H; Hirahara N; Kirichek O; Tawara R; Akiyama S; Katsumata M; Haruya M; Ishii T; Simard EP; Miller BE; Tal-Singer R; Kaise T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1771-1782. PubMed ID: 34168439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Three Screening Questionnaires for Chronic Obstructive Pulmonary Disease in the Primary Care.
    Spyratos D; Haidich AB; Chloros D; Michalopoulou D; Sichletidis L
    Respiration; 2017; 93(2):83-89. PubMed ID: 28052294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
    Martinez CH; Murray S; Barr RG; Bleecker E; Bowler RP; Christenson SA; Comellas AP; Cooper CB; Couper D; Criner GJ; Curtis JL; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Kleerup E; Krishnan JA; Lazarus SC; Leidy NK; O'Neal W; Martinez FJ; Paine R; Rennard SI; Tashkin DP; Woodruff PG; Han MK;
    Ann Am Thorac Soc; 2017 May; 14(5):636-642. PubMed ID: 28459622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of the PUMA COPD diagnostic questionnaire in a general practice sample and the PLATINO study population.
    Lopez Varela MV; Montes de Oca M; Wehrmeister FC; Rodriguez C; Ramirez L; Menezes A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1901-1911. PubMed ID: 31692595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: the Hisayama study.
    Tsukuya G; Matsumoto K; Fukuyama S; Crawford B; Nakanishi Y; Ichinose M; Machida K; Samukawa T; Ninomiya T; Kiyohara Y; Inoue H;
    Allergol Int; 2015 Jan; 64(1):49-53. PubMed ID: 25572558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
    Li L; Liu Y; Li J; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening.
    Mets OM; Schmidt M; Buckens CF; Gondrie MJ; Isgum I; Oudkerk M; Vliegenthart R; de Koning HJ; van der Aalst CM; Prokop M; Lammers JW; Zanen P; Mohamed Hoesein FA; Mali WP; van Ginneken B; van Rikxoort EM; de Jong PA
    Respir Res; 2013 May; 14(1):59. PubMed ID: 23711184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study.
    Kirby M; Tanabe N; Tan WC; Zhou G; Obeidat M; Hague CJ; Leipsic J; Bourbeau J; Sin DD; Hogg JC; Coxson HO; ; ;
    Am J Respir Crit Care Med; 2018 Jan; 197(1):56-65. PubMed ID: 28886252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of five surveys that identify individuals at risk for airflow obstruction and chronic obstructive pulmonary disease.
    Sogbetun F; Eschenbacher WL; Welge JA; Panos RJ
    Respir Med; 2016 Nov; 120():1-9. PubMed ID: 27817804
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.